Cleared Traditional

Happy Ring Health Monitoring System (K240236) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2024
Decision
239d
Days
Class 2
Risk

K240236 is an FDA 510(k) clearance for the Happy Ring Health Monitoring System. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Happy Health, Inc. (Austin, US). The FDA issued a Cleared decision on September 24, 2024 after a review of 239 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Happy Health, Inc. devices

Submission Details

510(k) Number K240236 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 29, 2024
Decision Date September 24, 2024
Days to Decision 239 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
114d slower than avg
Panel avg: 125d · This submission: 239d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Rx Device Consulting
Rakesh Lal

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 111
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K240236.
Welch Allyn Connex® Spot Monitor
K241411 · Welch Allyn, Inc. · Dec 2024
Sensinel Cardiopulmonary Management (CPM) System (ADCP1100)
K243216 · Analog Devices · Dec 2024
AMC Health CareConsole
K233446 · Amc Health · Sep 2024
WVSM Pro (Series) (500-0030-XX)
K233354 · Athena Gtx, Inc. · Jun 2024
NeoBeat, NeoBeat Mini
K232111 · Laerdal Medical AS · Jun 2024
Portrait VSM
K233810 · Ge Medical Systems Information Technologies, Inc. · Apr 2024